1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Vidal, M. Gincel, E. Goudreau, N. Cornille, F. Parker, F. Duchesne, M. Tocque, B. Garbay, C. Roques, B.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 290 717 730 10.1006/jmbi.1999.2899 10395825 Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin. 1999 US Nat.Struct.Biol. NSBIEW 2024 1072-8368 1 898 NMR Structure of the N-Terminal SH3 Domain of Grb2 and its Complex with a Proline-Rich Peptide from SOS 1994 10.2210/pdb1aze/pdb pdb_00001aze 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6477.309 GRB2 N-TERMINAL SH3 DOMAIN, RESIDUES 1 - 55 Y7V, C32S 1 man polymer 1173.432 SOS BINDING SITE IN H-SOS, PEPTIDE VPPPVPPRRR 1 man polymer ASH, GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 no no MEAIAKVDFKATADDELSFKRGDILKVLNEESDQNWYKAELNGKDGFIPKNYIEMK MEAIAKVDFKATADDELSFKRGDILKVLNEESDQNWYKAELNGKDGFIPKNYIEMK A polypeptide(L) no no VPPPVPPRRR VPPPVPPRRR B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample GRB2 9606 FRUIT Homo sapiens fruit fly Drosophila sample 7227 Drosophila melanogaster database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1999-05-18 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name _struct_ref_seq_dif.details Y BNL 1997-11-17 REL REL BEST ENERGY, LEAST RESTRAINT VIOLATION 50 10 NOESY TOCSY COSY NACL 100mM 6.0 1 atm 293 K SIMULATED ANNEALING ENERGY MINIMIZATION H2O, PHOSPHATE BUFFER 20MM, NACL 100MM BIOSYM refinement Discover 2.95 structure solution BRUKER UXNMR + DISCOVER DISCOVER 600 Bruker AMX600 MET 1 n 1 MET 1 A GLU 2 n 2 GLU 2 A ALA 3 n 3 ALA 3 A ILE 4 n 4 ILE 4 A ALA 5 n 5 ALA 5 A LYS 6 n 6 LYS 6 A VAL 7 n 7 VAL 7 A ASP 8 n 8 ASP 8 A PHE 9 n 9 PHE 9 A LYS 10 n 10 LYS 10 A ALA 11 n 11 ALA 11 A THR 12 n 12 THR 12 A ALA 13 n 13 ALA 13 A ASP 14 n 14 ASP 14 A ASP 15 n 15 ASP 15 A GLU 16 n 16 GLU 16 A LEU 17 n 17 LEU 17 A SER 18 n 18 SER 18 A PHE 19 n 19 PHE 19 A LYS 20 n 20 LYS 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A ASP 23 n 23 ASP 23 A ILE 24 n 24 ILE 24 A LEU 25 n 25 LEU 25 A LYS 26 n 26 LYS 26 A VAL 27 n 27 VAL 27 A LEU 28 n 28 LEU 28 A ASN 29 n 29 ASN 29 A GLU 30 n 30 GLU 30 A GLU 31 n 31 GLU 31 A SER 32 n 32 SER 32 A ASP 33 n 33 ASP 33 A GLN 34 n 34 GLN 34 A ASN 35 n 35 ASN 35 A TRP 36 n 36 TRP 36 A TYR 37 n 37 TYR 37 A LYS 38 n 38 LYS 38 A ALA 39 n 39 ALA 39 A GLU 40 n 40 GLU 40 A LEU 41 n 41 LEU 41 A ASN 42 n 42 ASN 42 A GLY 43 n 43 GLY 43 A LYS 44 n 44 LYS 44 A ASP 45 n 45 ASP 45 A GLY 46 n 46 GLY 46 A PHE 47 n 47 PHE 47 A ILE 48 n 48 ILE 48 A PRO 49 n 49 PRO 49 A LYS 50 n 50 LYS 50 A ASN 51 n 51 ASN 51 A TYR 52 n 52 TYR 52 A ILE 53 n 53 ILE 53 A GLU 54 n 54 GLU 54 A MET 55 n 55 MET 55 A LYS 56 n 56 LYS 56 A VAL 1 n 1 VAL 1 B PRO 2 n 2 PRO 2 B PRO 3 n 3 PRO 3 B PRO 4 n 4 PRO 4 B VAL 5 n 5 VAL 5 B PRO 6 n 6 PRO 6 B PRO 7 n 7 PRO 7 B ARG 8 n 8 ARG 8 B ARG 9 n 9 ARG 9 B ARG 10 n 10 ARG 10 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O ALA 3 A O ALA 3 A N LEU 25 A N LEU 25 A O LYS 26 A O LYS 26 A N GLU 40 A N GLU 40 A O TYR 37 A O TYR 37 A N ILE 48 A N ILE 48 1 A CB ILE 48 WRONG HAND 1 A CB ILE 53 WRONG HAND 2 A CB ILE 4 WRONG HAND 2 A CB THR 12 WRONG HAND 2 A CB ILE 24 WRONG HAND 2 A CB ILE 48 WRONG HAND 2 A CB ILE 53 WRONG HAND 3 A CB ILE 24 WRONG HAND 3 A CB ILE 48 WRONG HAND 3 A CB ILE 53 WRONG HAND 4 A CB ILE 4 WRONG HAND 4 A CB THR 12 WRONG HAND 4 A CB ILE 24 WRONG HAND 5 A CB THR 12 WRONG HAND 5 A CB ILE 24 WRONG HAND 6 A CB ILE 24 WRONG HAND 6 A CB ILE 53 WRONG HAND 7 A CB ILE 24 WRONG HAND 8 A CB ILE 4 WRONG HAND 9 A CB THR 12 WRONG HAND 9 A CB ILE 48 WRONG HAND 10 A CB ILE 4 WRONG HAND 1 A TYR 37 0.102 SIDE CHAIN 3 A TYR 37 0.101 SIDE CHAIN 4 A TYR 37 0.097 SIDE CHAIN 1 A A C OXT LYS LYS 56 56 0.134 0.019 1.229 1.363 N 2 A A C OXT LYS LYS 56 56 0.134 0.019 1.229 1.363 N 3 A A C OXT LYS LYS 56 56 0.135 0.019 1.229 1.364 N 4 A A C OXT LYS LYS 56 56 0.136 0.019 1.229 1.365 N 5 A A C OXT LYS LYS 56 56 0.137 0.019 1.229 1.366 N 6 A A C OXT LYS LYS 56 56 0.133 0.019 1.229 1.362 N 7 A A C OXT LYS LYS 56 56 0.134 0.019 1.229 1.363 N 8 A A C OXT LYS LYS 56 56 0.132 0.019 1.229 1.361 N 9 A A C OXT LYS LYS 56 56 0.134 0.019 1.229 1.363 N 10 A A C OXT LYS LYS 56 56 0.134 0.019 1.229 1.363 N 1 A ASP 15 -158.97 -44.52 1 A SER 32 -168.45 -57.67 1 A LEU 41 -71.04 -74.25 1 A ASN 42 -167.59 -59.31 1 B ARG 9 83.80 130.27 2 A ASP 15 -156.24 39.27 2 A ASP 33 -156.13 86.74 2 A ASN 35 -82.51 49.47 2 B ARG 9 83.37 158.51 3 A ALA 13 -170.41 144.09 3 A ASP 15 -162.12 -61.57 3 A LYS 20 -97.38 -123.60 3 A GLU 30 -54.88 -70.27 3 A SER 32 74.71 118.27 3 A ASN 42 -13.32 -62.53 3 A MET 55 -63.36 -80.36 4 A ASP 15 -170.09 -40.65 4 A LYS 20 -100.73 -93.81 4 A ARG 21 -172.70 127.50 4 A LEU 28 -90.00 -105.81 4 A ASN 29 -150.36 -75.37 4 A SER 32 69.71 -65.38 4 A ASN 35 -170.68 -43.05 4 A TYR 52 -85.88 39.66 4 A GLU 54 -69.80 -80.74 4 A MET 55 52.96 83.55 5 A THR 12 -88.77 -70.48 5 A ASP 15 -155.90 -46.64 5 A LEU 28 -89.79 -76.73 5 A GLU 31 -123.05 -51.20 5 A SER 32 -159.31 -82.68 5 A ASN 42 -159.61 -45.22 5 A ASN 51 -159.97 -53.75 5 A MET 55 -66.82 94.62 6 A ASP 8 -69.92 91.50 6 A ASP 15 -165.78 -47.73 6 A LEU 28 -93.68 -68.79 6 A GLU 30 -173.41 -99.68 6 A GLU 31 -132.34 -55.08 6 A SER 32 -161.72 -75.17 6 A ASP 33 -148.46 50.90 6 A ASN 42 -176.41 -56.65 6 A ASN 51 -165.13 -60.00 6 B ARG 8 -69.31 -72.41 7 A THR 12 -132.95 -42.28 7 A GLU 31 -46.92 -73.21 7 A SER 32 59.61 -158.51 7 A GLN 34 -137.56 -61.05 7 A ASN 35 104.02 -12.07 7 A LEU 41 -108.79 -90.61 7 A GLU 54 -78.29 -72.91 7 A MET 55 45.03 74.09 8 A ASP 15 -160.21 -57.25 8 A SER 18 82.62 127.05 8 A GLU 30 -75.86 -121.52 8 A GLU 31 -79.87 -77.53 8 A SER 32 60.36 -141.67 8 A GLN 34 62.57 -178.86 8 A LEU 41 -139.04 -119.08 9 A LYS 6 -89.79 46.20 9 A VAL 7 -147.96 -60.96 9 A ASP 8 96.02 118.30 9 A THR 12 -147.04 52.67 9 A ASP 15 -159.84 -66.05 9 A LYS 20 -122.96 -131.70 9 A GLU 31 -67.06 84.98 9 A ASN 42 -172.06 -50.38 9 A MET 55 74.50 -56.28 10 A ASP 8 -66.70 99.31 10 A GLU 16 -59.28 175.76 10 A GLU 30 -159.41 -51.05 10 A GLU 31 66.60 -17.30 10 A ASP 33 -167.16 -40.71 10 A LEU 41 -88.15 -81.48 10 A ASN 42 -172.08 58.35 10 B ARG 8 -70.80 -77.67 10 B ARG 9 -164.72 85.27 NMR STRUCTURE OF THE COMPLEX BETWEEN THE C32S-Y7V MUTANT OF THE NSH3 DOMAIN OF GRB2 WITH A PEPTIDE FROM SOS, 10 STRUCTURES 1 N N 2 N N COMPLEX (ADAPTOR PROTEIN/PEPTIDE) COMPLEX (ADAPTOR PROTEIN-PEPTIDE), SH3 DOMAIN, GUANINE-NUCLEOTIDE RELEASING FACTOR, COMPLEX (ADAPTOR PROTEIN-PEPTIDE) complex GRB2_HUMAN UNP 1 1 P62993 SOS_DROME UNP 2 1342 P26675 1 56 1AZE 1 56 P62993 A 1 1 56 1342 1350 1AZE 1 9 P26675 B 2 1 9 1 TYR engineered mutation VAL 7 1AZE A P62993 UNP 7 7 1 CYS engineered mutation SER 32 1AZE A P62993 UNP 32 32 4 anti-parallel anti-parallel anti-parallel A GLU 2 A GLU 2 A ILE 4 A ILE 4 A ILE 24 A ILE 24 A ASN 29 A ASN 29 A TRP 36 A TRP 36 A GLU 40 A GLU 40 A ASP 45 A ASP 45 A PRO 49 A PRO 49 1 P 1